Investors

Latest results

From quarterly updates to key announcements, here you can access all GSK investor-related information.

Scroll to explore

We’re confident in our future

Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.

Latest announcements and results

2022 Full year and fourth quarter results announcement

Quarterly results
01 February 2023

We announced our full year and fourth quarter results for the period which ended 31 December 2022 on Wednesday 1 February.

 

DNA science image

GSK publishes Prospectus and Circular

Press release

We have published the Prospectus and Circular for the proposed demerger of our Consumer Healthcare business to form Haleon.

 

Immuno oncology science image

Completion of the demerger of Haleon and share consolidation of GSK

Press release
18 July 2022

GSK plc has today completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group. 

Shingles cell

Completion of GSK Share Consolidation

Press release
18 July 2022

GSK plc is pleased to announce that further to the Circular and Notice of General Meeting published by GSK on 1 June 2022, and following the announcements of 6 July 2022 that shareholder approval was granted at the GSK General Meeting and of 18 July 2022 that GSK has completed the demerger of the Consumer Healthcare business from the GSK Group to form Haleon.

Key dates

26
Apr

Q1 2023 results

We will announce our first quarter 2023 results on Wednesday 26 July.

26
Jul

Q2 2023 results

We will announce our second quarter 2023 results on Wednesday 26 July.

two scientists talking

Get in touch with our investor team

Back to top